ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Taken together, we here for the first time present a protocol for separation and isolation of both BCR::ABL1+ LSCs and BCR::ABL1- HSCs from the same CML patients, two populations evidently relevant to therapy response.